Page 2 - ரேர் நடவடிக்கை வலைப்பின்னல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New Report Finds Medical Treatments for Rare Diseases Account for Only 11% of US Drug Spending; Nearly 80% of Orphan Products Treat Rare Diseases Exclusively Majority of pharmaceuticals sales are driven by treatments for common conditions, not rare diseases News provided by Share this article Share this article WASHINGTON, March 4, 2021 /PRNewswire/ As US policymakers consider options to address rising health care costs while still meeting the needs of patients, a new report from IQVIA has found that rare diseases account for just 11% of medical invoice spending in the United States, and 79% of all orphan products treat only rare diseases. The report also highlights recent progress in drug development that has resulted in more people with rare diseases having access to critical treatments.

United statesPeterl saltonstallNational organization for rare disordersRare action networkDrug administrationNational organizationRare disordersOrphan drug actRare disease innovationCost trends throughAction networkNational organization for rare disorders nordஒன்றுபட்டது மாநிலங்களில்தேசிய ஆர்கநைஸேஶந் க்கு ரேர் கோளாறுகள்ரேர் நடவடிக்கை வலைப்பின்னல்தேசிய ஆர்கநைஸேஶந்